Etidronate disodium, Thermo Scientific Chemicals
Etidronate disodium, Thermo Scientific Chemicals
Thermo Scientific Chemicals

Etidronate disodium, Thermo Scientific Chemicals

 
Have Questions?
Quantity:
1 g
This chemical may require us to obtain additional information for our regulatory and chemical compliance records. If required, we will contact you for this information once your order is placed.
Catalog number J62381.03
also known as J62381-03
Price (EUR)/ Each
351,00
Online exclusive
390,00 
Save 39,00 (10%)
-
Add to cart
Quantity:
1 g
Request bulk or custom format
Price (EUR)/ Each
351,00
Online exclusive
390,00 
Save 39,00 (10%)
Add to cart
Etidronate disodium, Thermo Scientific Chemicals
Catalog numberJ62381.03
Price (EUR)/ Each
351,00
Online exclusive
390,00 
Save 39,00 (10%)
-
Add to cart
Specifications
Chemical Name or MaterialEtidronate disodium
CAS7414-83-7
Health Hazard 1H302-H315-H319
Health Hazard 2GHS H Statement
H302
Harmful if swallowed.
Health Hazard 3P264b-P270-P280-P301+P312-P302+P352-P305+P351+P338-P330-P332+P313-P362-P501c
View more
Etidronate disodium is used as a bisphosphonate bone resorption inhibitor. Etidronic acid is used as a calcium regulator. Etidronic acid is a bisphosphonate antiresorptive agent.

This Thermo Scientific Chemicals brand product was originally part of the Alfa Aesar product portfolio. Some documentation and label information may refer to the legacy brand. The original Alfa Aesar product / item code or SKU reference has not changed as a part of the brand transition to Thermo Scientific Chemicals.

Applications
Etidronate disodium is used as a bisphosphonate bone resorption inhibitor. Etidronic acid is used as a calcium regulator. Etidronic acid is a bisphosphonate antiresorptive agent.

Solubility
Soluble in water (26 mg/m
RUO – Research Use Only

General References:

  1. RP Heaney.; PD Saville. Etidronate disodium in postmenopausal osteoporosis. Clinical pharmacology and therapeutics. 1976, 20(5), 593-604.
  2. N Shiraishi.; K Kitamura.;T Miyoshi.; M Adachi. Successful treatment of a patient with severe calcific uremic arteriolopathy (calciphylaxis) byetidronate disodium. American Journal of Kidney Diseases. 2006, 48(1), 151-154.